Different Treatments of Symptomatic Angiomyolipomas of the Kidney: Two Case Reports
Main Article Content
Keywords
angiomyolipomas, cryoablation, transarterial embolization
Abstract
Development of more sensitive imaging techniques has caused an increase in the number of diagnosed small renal tumors. Approximately 2–3% of these lesions are proved to be angiomyolipomas (AML), a rare benign tumor of the kidney sometimes causing pain and hematuria. The most required approach is observation, but in the case of recurrent symptoms or larger tumors, which may cause bleeding, a more active treatment is required. We present two cases of symptomatic AML tumors of different sizes in the kidney: one treated with transarterial embolization (TAE), and the other with percutaneous cryoablation (CRA). The lesions were diagnosed on the basis of contrast-enhanced computed tomography (CT) scan and magnetic resonance imaging (MRI). Both treatments proved to be effective and safe for treating renal AMLs. A follow-up carried out, based on contrast-enhanced CT scan, confirmed complete treatment of AML and decreased lesion size. There are myriad minimally invasive approaches for the treatment of renal AMLs, and the preservation of renal function remains a priority. The most popular treatment option is the selective renal artery embolization. Owing to its limited invasiveness, CRA could be an attractive option for the preventive treatment of AML.
References
2. Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD. Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J. 2010;51(5):728–34. 10.3349/ymj.2010.51.5.728
3. Martignoni G, Amin MB. Angiomyolipoma. World Health Organization classification of tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press; 2004. p. 65–7.
4. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168(4, Pt 1):1315–25. 10.1016/S0022-5347(05)64440-0
5. Oesterling JE, Fishman EK, Goldman SM, Marshall FF. Themanagement of renal angiomyolipoma. J Urol. 1986;135:1121–4. 10.1016/S0022-5347(17)46013-7
6. Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int. 2004;66(3):924–34. 10.1111/j.1523-1755.2004.00838.x
7. Lemaitre L, Claudon M, Dubrulle F, Mazeman E. Imaging of angiomyolipomas. Semin Ultrasound CT MR. 1997;18(2):100–14. 10.1016/S0887-2171(97)90054-8
8. Sivalingam S, Nakada SY. Contemporary minimally invasive treatment options for renal angiomyolipomas. Curr Urol Rep. 2013;14:147–53. 10.1007/s11934-013-0311-3
9. Ramon J, Rimon U, Garniek A, Golan G, Bensaid P, Kitrey ND, et al. Renal angiomyolipoma: Long-term results following selective arterial embolization. Eur Urol. 2009;55:1155–61. 10.1016/j.eururo.2008.04.025
10. Hocquelet A, Cornelis F, Le Bras Y, Meyer M, Tricaud E, Lasserre AS, et al. Long-term results of preventive embolization of renal angiomyolipomas: Evaluation of predictive factors of volume decrease. Eur Radiol. 2014;24:1785–93. 10.1007/s00330-014-3244-4
11. Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: A systematic review. J Urol. 2015;194:635–9. 10.1016/j.juro.2015.04.081
12. Staehler M, Sauter M, Helck A, Linsenmaier U, Weber L, Mayer K. Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis. Int Urol Nephrol. 2012;44:1657–61. 10.1007/s11255-012-0292-z
13. Castle SM, Gorbatiy V, Ekwenna O, Young E, Leveillee RJ. Radio-frequency ablation (RFA) therapy for renal angiomyolipoma (AML): An alternative to angio-embolization and nephron-sparing surgery. BJU Int. 2012;109:384–7. 10.1111/j.1464-410X.2011.10376.x
14. Fernandez-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, et al. Management of sporadic renal angiomyolipomas: A systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Urol Oncol. 2020 Feb;3(1):57–72. 10.1016/j.euo.2019.04.005
15. Muller A, Rouvie`re O. Renal artery embolization: indications, technical approaches and outcomes. Nat Rev Nephrol. 2015;11(5):288–301. 10.1038/nrneph.2014.231
16. Kuusk T, Biancari F, Lane B, Tobert C, Campbell S, Rimon U, et al. Treatment of renal angiomyolipoma: Pooled analysis of individual patient data. BMC Urol. 2015;15(1):123. 10.1186/s12894-015-0118-2
17. Kiefer RM, Stavropoulos SW. The role of interventional radiologytechniques in the management of renal angiomyolipomas. Curr Urol Rep. 2017;18(5):36. 10.1007/s11934-017-0687-6
18. Castle SM, Gorbatiy V, Ekwenna O, Young E, Leveillee RJ. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): An alternative to angio-embolization and nephron-sparing surgery. BJU Int. 2012;109:384–7. 10.1111/j.1464-410X.2011.10376.x
19. Byrd GF, Lawatsch EJ, Mesrobian HG, Begun F, Langenstroer P. Laparoscopic cryoablation of renal angiomyolipoma. J Urol. 2006;176:1512–6. 10.1016/j.juro.2006.06.013
20. Johnson SC, Graham S, D´Agostino H, Elmajian DA, Shingleton WB. Percutanous renal cryoablation of angiomyolipomas in patients with solitary kidneys. Urology. 2009;74:1246–9. 10.1016/j.urology.2008.09.005
21. Makki A, Høyerc OGS, Solvigd J, Østraata Ø, Madsena MG, Nielsena TK. Cryoablation of renal angiomyolipoma—An evaluation of safety and efficacy. J Endourol. 2017 Nov;31(11):1117–22. 10.1089/end.2017.0376
22. Matuszewski M, Michajłowski J, Bianek-Bodzak A, Krajka K. Radiofrequency ablation of small symptomatic angiomyolipomas of the kidney: Report of two cases. Pol J Radiol. 2010 Jul;75(3):68–71.
23. Margulis V, Maatsumoto ED, Lindberg G, Tunc L, Taylor G, Sagalowsky AI, et al. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology. 2004;64(4):660–3. 10.1016/j.urology.2004.05.023